Correlation of Serum Levels of Vitronectin, Malondialdehyde and Hs- CRP With Disease Severity in Coronary Artery Disease. 2015

Alireza Yaghoubi, and Morteza Ghojazadeh, and Sakhavat Abolhasani, and Hossein Alikhah, and Fatemeh Khaki-Khatibi
Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

BACKGROUND Vitronectin (VN), malondialdehyde (MDA) and high-sensitivity C-reactive rotein (hs-CRP) are cooperative agents involved in the atherosclerosis process. The study was conducted to assess the correlation of VN, MDA and hs-CRP with the severity of coronary artery disease (CAD). METHODS Parameters such as serum VN, MDA and hs-CRP were measured in 250 subjects including 200 patients with angiographically diagnosed CAD (50 subjects with non-significant CAD, 50 with single vessel disease, 50 with double vessel disease, and 50 with triple vessel disease) and 50 CAD-free subjects as a control group. Serum VN was measured with ELISA; MDA was measured based on reaction with thiobarbituric acid (TBA); and hs-CRP level was measured by a Commercial Kit by Immunoturbidimetry. RESULTS Serum VN, MDA and hs-CRP were significantly higher in patient groups compared to control group (P < .05). The mean value of MDA between 1 vessel and 3 vessel groups had significant difference (P = .01), also mean value of MDA between 2 vessel and control group and normal group showed significant difference (P < .001). The difference of MDA between 3 vessel and normal and 1 vessel and control group was significant (P < .001). CONCLUSIONS The association and correlation between VN, MDA and hs-CRP indicate their involvement in the atherosclerosis process that may lead to progression of CAD. Also, these findings suggested that serum levels of VN, MDA and hs-CRP can help as diagnostic and monitoring markers in CAD patients and as markers of disease severity.

UI MeSH Term Description Entries

Related Publications

Alireza Yaghoubi, and Morteza Ghojazadeh, and Sakhavat Abolhasani, and Hossein Alikhah, and Fatemeh Khaki-Khatibi
January 2016, Clujul medical (1957),
Alireza Yaghoubi, and Morteza Ghojazadeh, and Sakhavat Abolhasani, and Hossein Alikhah, and Fatemeh Khaki-Khatibi
May 2014, Experimental and therapeutic medicine,
Alireza Yaghoubi, and Morteza Ghojazadeh, and Sakhavat Abolhasani, and Hossein Alikhah, and Fatemeh Khaki-Khatibi
July 2020, Scandinavian journal of clinical and laboratory investigation,
Alireza Yaghoubi, and Morteza Ghojazadeh, and Sakhavat Abolhasani, and Hossein Alikhah, and Fatemeh Khaki-Khatibi
July 2014, Indian journal of clinical biochemistry : IJCB,
Alireza Yaghoubi, and Morteza Ghojazadeh, and Sakhavat Abolhasani, and Hossein Alikhah, and Fatemeh Khaki-Khatibi
December 2017, International journal of cardiology,
Alireza Yaghoubi, and Morteza Ghojazadeh, and Sakhavat Abolhasani, and Hossein Alikhah, and Fatemeh Khaki-Khatibi
January 2022, Cellular and molecular biology (Noisy-le-Grand, France),
Alireza Yaghoubi, and Morteza Ghojazadeh, and Sakhavat Abolhasani, and Hossein Alikhah, and Fatemeh Khaki-Khatibi
January 2021, Journal of healthcare engineering,
Alireza Yaghoubi, and Morteza Ghojazadeh, and Sakhavat Abolhasani, and Hossein Alikhah, and Fatemeh Khaki-Khatibi
February 2024, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Alireza Yaghoubi, and Morteza Ghojazadeh, and Sakhavat Abolhasani, and Hossein Alikhah, and Fatemeh Khaki-Khatibi
April 2018, International journal of cardiology,
Alireza Yaghoubi, and Morteza Ghojazadeh, and Sakhavat Abolhasani, and Hossein Alikhah, and Fatemeh Khaki-Khatibi
April 2001, International journal of cardiology,
Copied contents to your clipboard!